Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nosocomial bloodstream infections (BSIs) are important causes of morbidity and mortality in the United States. METHODS: Data from a nationwide, concurrent surveillance study (Surveillance and Control of Pathogens of Epidemiological Importance [SCOPE]) were used to examine the secular trends in the epidemiology and microbiology of nosocomial BSIs. RESULTS: Our study detected 24,179 cases of nosocomial BSI in 49 US hospitals over a 7-year period from March 1995 through September 2002 (60 cases per 10,000 hospital admissions). Eighty-seven percent of BSIs were monomicrobial. Gram-positive organisms caused 65% of these BSIs, gram-negative organisms caused 25%, and fungi caused 9.5%. The crude mortality rate was 27%. The most-common organisms causing BSIs were coagulase-negative staphylococci (CoNS) (31% of isolates), Staphylococcus aureus (20%), enterococci (9%), and Candida species (9%). The mean interval between admission and infection was 13 days for infection with Escherichia coli, 16 days for S. aureus, 22 days for Candida species and Klebsiella species, 23 days for enterococci, and 26 days for Acinetobacter species. CoNS, Pseudomonas species, Enterobacter species, Serratia species, and Acinetobacter species were more likely to cause infections in patients in intensive care units (P<.001). In neutropenic patients, infections with Candida species, enterococci, and viridans group streptococci were significantly more common. The proportion of S. aureus isolates with methicillin resistance increased from 22% in 1995 to 57% in 2001 (P<.001, trend analysis). Vancomycin resistance was seen in 2% of Enterococcus faecalis isolates and in 60% of Enterococcus faecium isolates. CONCLUSION: In this study, one of the largest multicenter studies performed to date, we found that the proportion of nosocomial BSIs due to antibiotic-resistant organisms is increasing in US hospitals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the United States and elsewhere, Candida species are a leading cause of health care–associated bloodstream infections (3–5).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [4]
In the citing paper
“The incidence of nosocomial candidiasis has increased over the past few decades [28,29,30,31,32].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Candidaemia is the most common form of invasive candidiasis associated with an unacceptably high mortality rates in excess of 40% even with the introduction of newer antifungal agents [30,32,33].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Data from a US surveillance study found that over a 7year period Candida spp.accounted for 4.6 bloodstream infections per 10,000 admissions and 9% of all bloodstream infections [1], whereas the incidence may vary between centers.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
In the citing paper
“Among documented invasive fungal infections, candidemia and invasive candidiasis are encountered with increasing incidence in nosocomial settings [1].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[30] showed that mortality rates doubled, from 30% to 60%, when inappropriate empirical antibiotic therapy was given to ICU patients with BSIs.”
BackgroundNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387 · cited 3×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundMethodSelf-citationDiekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundWeinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228 · cited 1×
“Recent studies have shown that the proportion of contaminants is lower if 2 or more positive blood culture results (of samples drawn within a few hours of each other) were required for inclusion [9, 32, 33].”
BackgroundPittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Kreger, B. E., Craven, D. E., Carling, P. C., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90101-1 · Cited by 595 · cited 1×
“The crude rate mortality ranged from 12% in total hospital populations to 80% in ICU patients [6–10].”
BackgroundEmergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundFridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
Research works printed but not linked: 1
- 1996, 77, 791, 10.1002/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V · DOI · Paper page
Cited by
Items 101–200 of 1,033
Cleveland, A. A., Farley, M. M., Harrison, L. H., Stein, B., Hollick, R., Lockhart, S. R., Magill, S. S., Derado, G., Park, B. J., & Chiller, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis697 · Cited by 366
“Candida species are among the most common causes of BSIs and are associated with high morbidity and mortality, as well as increases in hospital cost and length of stay [1–5].”
Prevention and Treatment of Cancer-Related Infections
Baden, L. R., Bensinger, W., Angarone, M., Casper, C., Dubberke, E. R., Freifeld, A. G., Garzon, R., Greene, J. N., Greer, J. P., Ito, J. I., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0146 · Cited by 368
Branski, L. K., Al-Mousawi, A., Rivero, H., Jeschke, M. G., Sanford, A. P., & Herndon, D. N. (2009) · Surgical Infections · doi:10.1089/sur.2009.024 · Cited by 365
“Candida spp. are the most common cause of fungal sepsis [49] and the fourth most common organism causing infection overall.”
A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families
Vyas, V. K., Barrasa, M. I., & Fink, G. R. (2015) · Science Advances · doi:10.1126/sciadv.1500248 · Cited by 362
The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace
Roca, I., Espinal, P., Vila-Farrés, X., & Vila, J. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00148 · Cited by 363
Candida albicans Als3, a multifunctional adhesin and invasin
Liu, Y., & Filler, S. G. (2011) · Eukaryotic Cell · doi:10.1128/ec.00279-10 · Cited by 354
“are the fourth most common cause of nosocomial bloodstream infections, and Candida albicans accounts for approximately 50% of cases of candidemia (20, 67).”
BackgroundCinnamaldehyde and its derivatives, a novel class of antifungal agents
Shreaz, S., Wani, W. A., Behbehani, J. M., Raja, V., Irshad, M., Karched, M., Ali, I., Siddiqi, W. A., & Hun, L. T. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.05.016 · Cited by 345
“This has resulted in a drastic increase in the incidence of opportunistic fungal infections [6-9], which is now a severe public health problem [10,11].”
BackgroundAlbuquerque, P. C., Nakayasu, E. S., Rodrigues, M. L., Frases, S., Casadevall, A., Zancope-Oliveira, R. M., Almeida, I. C., & Nosanchuk, J. D. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01160.x · Cited by 351
“tion in the US (Wisplinghoff et al., 2004).”
Falagas, M. E., Roussos, N., & Vardakas, K. Z. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.04.006 · Cited by 346
“…1143 45% 24% 13% 12% 2% - 1% - - 0.9% - 0.2% The study showed an increasing frequency of C. glabrata (consistent with the results of previous studies) Wisplinghoff et al., 2004 [2] Prospective, 1995–2002, SCOPE nationwide surveillance study NA 1890 53.8% 18.8% 11.4% 11.2% 2.4% - - - - - -…”
BackgroundInfluentialRodríguez‐Baño, J., Picón, E., Gijón, P., Hernández, J. R., Ruíz, M., Peña, C., Almela, M., Almirante, B., Grill, F., Colomina, J., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649537 · Cited by 347
A nuclear receptor-like pathway regulating multidrug resistance in fungi
Thakur, J. K., Arthanari, H., Yang, F., Pan, S.-J., Fan, X., Breger, J., Frueh, D. P., Gulshan, K., Li, D. K., Mylonakis, E., et al. (2008) · Nature · doi:10.1038/nature06836 · Cited by 343
Multidrug-Resistant Enterobacter cloacae Complex Emerging as a Global, Diversifying Threat
Annavajhala, M. K., Gomez-Simmonds, A., & Uhlemann, A.-C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00044 · Cited by 340
“In particular, Enterobacter cloacae complex (ECC) are common nosocomial pathogens capable of producing a wide variety of infections, such as pneumonia, urinary tract infections, and septicemia (Sanders et al., 1997; Wisplinghoff et al., 2004).”
BackgroundNosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention
Alangaden, G. J. (2011) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.11.003 · Cited by 337
“6 per 10,000 hospital admissions.(4) Candida spp were the fourth most common pathogen isolated and accounted for 9%ofBSIs.”
InfluentialMorbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis
Koehler, P., Stecher, M., Cornely, O. A., Koehler, D., Vehreschild, M. J. G. T., Bohlius, J., Wisplinghoff, H., & Vehreschild, J. J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.024 · Cited by 336
Self-citationRole of coagulase-negative staphylococci in human disease
PIETTE, A., & VERSCHRAEGEN, G. (2009) · Veterinary Microbiology · doi:10.1016/j.vetmic.2008.09.009 · Cited by 318
“In a nation wide surveillance study in the USA, performed between 1995 and 2002, CNS accounted for 31% of all nosocomial BSI (Wisplinghoff et al., 2004).”
BackgroundInfluentialAntimicrobial Resistance in Gram-Positive Bacteria
Rice, L. B. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.012 · Cited by 276
Garcia-Effron, G., Lee, S., Park, S., Cleary, J. D., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00443-09 · Cited by 323
“glabrata infections are a concern due to their high mortality rates (38) and the tendency of this microorganism to rapidly develop resistance to azole antifungal agents (6, 11, 15, 25, 31, 34).”
BackgroundGuidelines for the Prevention of Intravascular Catheter–Related Infections
O'Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Masur, H., McCormick, R. D., Mermel, L. A., Pearson, M. L., et al. (2002) · Infection Control & Hospital Epidemiology · doi:10.1017/s0195941700080577 · Cited by 319
Acinetobacter infection – an emerging threat to human health
Visca, P., Seifert, H., & Towner, K. J. (2011) · IUBMB Life · doi:10.1002/iub.534 · Cited by 324
“3% of all monomicrobial nosocomial bloodstream infections (12).”
BackgroundSelf-citationBacterial skin commensals and their role as host guardians
Christensen, G. J. M., & Brüggemann, H. (2014) · Beneficial Microbes · doi:10.3920/bm2012.0062 · Cited by 319
“The detachment of bacterial cells from biofilms on these devices can lead to bacteremia (Wisplinghoff et al. , 2004), and S. epidermidis is the most frequently isolated species of coagulase-negative staphylococci from nosocomical bloodstream infections (Rupp and Archer, 1994).”
Immune Recognition of Candida albicans β‐glucan by Dectin‐1
Gow, N. A. R., Netea, M. G., Munro, C. A., Ferwerda, G., Bates, S., Mora‐Montes, H. M., Walker, L., Jansen, T., Jacobs, L., Tsoni, V., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/523110 · Cited by 314
“Invasive Candida albicans infections are a serious clinical threat in patients who are immunosuppressed and those who have undergone major surgical procedures, with mortality reaching 30%-40% despite the availability of new classes of antifungal drugs [1, 2].”
Emerging fungal infections in immunocompromised patients
Low, C.-Y., & Rotstein, C. (2011) · F1000 Medicine Reports · doi:10.3410/m3-14 · Cited by 309
“Introduction The incidence of invasive fungal infections is rising [1-3], and although they are not yet as much of a threat as bacterial pathogens, their increase is significant enough for us to realize that a sinister shift in epidemiology has been occurring, especially in oncology patients and transplant recipients.”
BackgroundAre coagulase-negative staphylococci virulent?
Heilmann, C., Ziebuhr, W., & Becker, K. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.11.012 · Cited by 298
The French Mycosis Study Group, Lortholary, O., Renaudat, C., Sitbon, K., Madec, Y., Denoeud-Ndam, L., Wolff, M., Fontanet, A., Bretagne, S., & Dromer, F. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3408-3 · Cited by 312
Staphylococcus aureus Bacteremia: Epidemiology, Pathophysiology, and Management Strategies
Naber, C. K. (2009) · Clinical Infectious Diseases · doi:10.1086/598189 · Cited by 313
“Staphylococcus aureus bloodstream infections are among the most prevalent and difficult to treat [1].”
BackgroundThe changing epidemiology of healthcare-associated candidemia over three decades
Diekema, D., Arbefeville, S., Boyken, L., Kroeger, J., & Pfaller, M. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.02.001 · Cited by 309
Lehmann, L. E., Hunfeld, K.-P., Emrich, T., Haberhausen, G., Wissing, H., Hoeft, A., & Stüber, F. (2008) · Medical Microbiology and Immunology · doi:10.1007/s00430-007-0063-0 · Cited by 313
“Analytical performance data obtained throughout our methodological study indicate good to excellent laboratory detection and diVerentiation capabilities for 25 bacterial and fungal microorganisms that are known to be most relevant in patients with BSI´s.”
BackgroundResultImplantable Device-Related Infection
VanEpps, J. S., & Younger, J. G. (2016) · Shock · doi:10.1097/shk.0000000000000692 · Cited by 306
“In general, the most common organism isolated from infected medical devices is coagulase negative staphylococci, typically Staphylococcus epidermidis (1, 59).”
BackgroundCleveland, A. A., Harrison, L. H., Farley, M. M., Hollick, R., Stein, B., Chiller, T. M., Lockhart, S. R., & Park, B. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120452 · Cited by 304
Antibacterial Liquid Metals: Biofilm Treatment via Magnetic Activation
Elbourne, A., Cheeseman, S., Atkin, P., Truong, N. P., Syed, N., Zavabeti, A., Mohiuddin, M., Esrafilzadeh, D., Cozzolino, D., McConville, C. F., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b07861 · Cited by 302
Platelets in defense against bacterial pathogens
Yeaman, M. R. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0210-4 · Cited by 303
Emerging Technologies for the Clinical Microbiology Laboratory
Buchan, B. W., & Ledeboer, N. A. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00003-14 · Cited by 297
“aureus is of major concern in BSIs, it comprises only about 20% of positive cultures (81).”
BackgroundIsta, E., van der Hoven, B., Kornelisse, R. F., van der Starre, C., Vos, M. C., Boersma, E., & Helder, O. K. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00409-0 · Cited by 290
Lockhart, S. R., Iqbal, N., Cleveland, A. A., Farley, M. M., Harrison, L. H., Bolden, C. B., Baughman, W., Stein, B., Hollick, R., Park, B. J., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01283-12 · Cited by 299
“, accounting for approximately 10% of health care-associated BSIs and one of the highest crude mortality rates (37).”
BackgroundChristner, M., Rohde, H., Wolters, M., Sobottka, I., Wegscheider, K., & Aepfelbacher, M. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01831-09 · Cited by 303
“Species distribution of these strains was in good agreement with larger surveys from similar populations (47).”
Wisplinghoff, H., Ebbers, J., Geurtz, L., Stefanik, D., Major, Y., Edmond, M. B., Wenzel, R. P., & Seifert, H. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.09.005 · Cited by 293
“Candida isolates were prospectively collected between 1998 and 2006 from patients with BSI in 52 geographically dispersed hospitals (range, 60–1200 beds) throughout the USA that participated in the SCOPE (Surveillance and Control of Pathogens of Epidemiological Importance) project [5].”
BackgroundMethodSelf-citationThe Clinical and Prognostic Importance of Positive Blood Cultures in Adults
Pien, B. C., Sundaram, P., Raoof, N., Costa, S. F., Mirrett, S., Woods, C. W., Reller, L. B., & Weinstein, M. P. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.03.021 · Cited by 293
Antibiotic resistance in Bangladesh: A systematic review
Ahmed, I., Rabbi, M. B., & Sultana, S. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.12.017 · Cited by 277
Identification of novel antimicrobials using a live-animal infection model
Moy, T. I., Ball, A. R., Anklesaria, Z., Casadei, G., Lewis, K., & Ausubel, F. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604055103 · Cited by 294
McCarty, T. P., & Pappas, P. G. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.013 · Cited by 285
A multicenter study of septic shock due to candidemia: Outcomes and predictors of mortality.
Bassetti, M., Righi, E., Ansaldi, F., Merelli, M., Cecilia, T., De Pascale, G., Diaz-Martin, A., Luzzati, R., Rosin, C., Lagunes, L., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3310-z · Cited by 284
“as the fifth most common isolates in nosocomial bloodstream infections [3, 4].”
BackgroundHealthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database*
Shorr, A. F., Tabak, Y. P., Killian, A. D., Gupta, V., Liu, L. Z., & Kollef, M. H. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000239121.09533.09 · Cited by 286
“0031 Other fungus, not Candida 24 (1) 27 (0.”
BackgroundInfluentialPathogenesis of Gram-Negative Bacteremia
Holmes, C. L., Anderson, M. T., Mobley, H. L. T., & Bachman, M. A. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00234-20 · Cited by 277
“pneumoniae is a leading pathogen in Gram-negative bacteremia and the third most common cause of HAIs overall (12, 18, 20, 25).”
BackgroundInfluentialEpidemiology of opportunistic fungal infections in Latin America
Nucci, M., Queiroz‐Telles, F., Tobón, A. M., Restrepo, A., & Colombo, A. L. (2010) · Clinical Infectious Diseases · doi:10.1086/655683 · Cited by 280
“tropicalis Brito et al [6] and Colombo et al [7] (March 2002–February 2003) Prospective, laboratorybased surveillance, 4 centers in São Paulo, Brazil, C.”
BackgroundTrautmann, M., Lepper, P. M., & Haller, M. (2005) · American Journal of Infection Control · doi:10.1016/j.ajic.2005.03.006 · Cited by 282
Healey, K. R., Zhao, Y., Perez, W. B., Lockhart, S. R., Sobel, J. D., Farmakiotis, D., Kontoyiannis, D. P., Sanglard, D., Taj-Aldeen, S. J., Alexander, B. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11128 · Cited by 276
Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency
Drewniak, A., Gazendam, R. P., Tool, A. T. J., van Houdt, M., Jansen, M. H., van Hamme, J. L., van Leeuwen, E. M. M., Roos, D., Scalais, E., de Beaufort, C., et al. (2013) · Blood · doi:10.1182/blood-2012-08-450551 · Cited by 277
“S aureus and Candida species are the second and third leading causes of bloodstream infections in hospitalized patients.(28) These organisms jointly cause at least 150 000 clinical bloodstream infections resulting in very large health care expenditures and ;40 000 deaths per year in the United States and Europe each.”
BackgroundRodriguez-Bano, J., Navarro, M. D., Romero, L., Muniain, M. A., Cueto, M. D., Rios, M. J., Hernandez, J. R., & Pascual, A. (2006) · Clinical Infectious Diseases · doi:10.1086/508877 · Cited by 279
Uslan, D. Z. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.8.834 · Cited by 274
Pfaller, M. A., Messer, S. A., Moet, G. J., Jones, R. N., & Castanheira, M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.016 · Cited by 274
Properties and mechanisms of action of naturally occurring antifungal peptides
van der Weerden, N. L., Bleackley, M. R., & Anderson, M. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1260-1 · Cited by 271
Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series
Delsing, C. E., Gresnigt, M. S., Leentjens, J., Preijers, F., Frager, F. A., Kox, M., Monneret, G., Venet, F., Bleeker-Rovers, C. P., van de Veerdonk, F. L., et al. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-166 · Cited by 271
“Despite development of new classes of antifungal agents [1], the invasive fungal infections remain associated with unacceptable high mortality rates and represent a major cause of death worldwide [2-7].”
Lood, R., Winer, B. Y., Pelzek, A. J., Diez-Martinez, R., Thandar, M., Euler, C. W., Schuch, R., & Fischetti, V. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04641-14 · Cited by 272
“3% of all sepsis cases), it is associated with mortality rates of up to 58% (6).”
BackgroundRoscetto, E., Contursi, P., Vollaro, A., Fusco, S., Notomista, E., & Catania, M. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-35530-0 · Cited by 272
Recent insights into Candida albicans biofilm resistance mechanisms
Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271
“Bloodstream infections are associated with considerable attributable mortality rates varying from 30 to 70 % (Bouza et al. 2013; Falagas et al. 2006; Kibbler et al. 2003; Peng and Lu 2013; Wey et al. 1988; Wisplinghoff et al. 2004) and high healthcare costs with estimates ranging from millions to 1 billion dollars in…”
Sipsas, N. V., Lewis, R. E., Tarrand, J., Hachem, R., Rolston, K. V., Raad, I. I., & Kontoyiannis, D. P. (2009) · Cancer · doi:10.1002/cncr.24507 · Cited by 269
Marra, A. R., Camargo, L. F. A., Pignatari, A. C. C., Sukiennik, T., Behar, P. R. P., Medeiros, E. A. S., Ribeiro, J., Girão, E., Correa, L., Guerra, C., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00376-11 · Cited by 269
“Similar studies have been conducted in the United States and Europe, and relevant conclusions could be drawn from the data obtained (27, 29).”
BackgroundInfluentialSelf-citationFalagas, M. E., Bliziotis, I. A., & Siempos, I. I. (2006) · Critical Care · doi:10.1186/cc4869 · Cited by 272
“baumannii has been recognized as a leading cause of nosocomial pneumonia and bacteremia (related to central venous catheters or not) in several hospitals in various parts of the world [3-6].”
BackgroundPseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Wood, S. J., Kuzel, T. M., & Shafikhani, S. H. (2023) · Cells · doi:10.3390/cells12010199 · Cited by 254
Candidemia and Invasive Candidiasis
McCarty, T. P., White, C. M., & Pappas, P. G. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.007 · Cited by 260
“8, 61– ( CVCs ) and other”
Transcriptional regulation of carbohydrate metabolism in the human pathogen Candida albicans
Askew, C., Sellam, A., Epp, E., Hogues, H., Mullick, A., Nantel, A., & Whiteway, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000612 · Cited by 260
“species are the most common isolated agent in fungal infections and the fourth leading cause of nosocomial bloodstream infections in the United States, with an attributable mortality rate of approximately 38–49% and treatment costs estimated to be $1.7 billion annually”
BackgroundInfluentialCandidemia and invasive candidiasis in adults: A narrative review
Antinori, S., Milazzo, L., Sollima, S., Galli, M., & Corbellino, M. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.06.029 · Cited by 257
Interplay between Candida albicans and the mammalian innate host defense
Cheng, S.-C., Joosten, L. A. B., Kullberg, B.-J., & Netea, M. G. (2012) · Infection and Immunity · doi:10.1128/iai.06146-11 · Cited by 256
“Risk factors, such as neutropenia, systemic antibiotic exposure, a central venous catheter, and a prolonged intensive care unit (ICU) stay, predispose individuals to invasive and even life-threatening systemic candidiasis (118).”
BackgroundReview of Rapid Diagnostic Tests Used by Antimicrobial Stewardship Programs
Bauer, K. A., Perez, K. K., Forrest, G. N., & Goff, D. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu547 · Cited by 250
“Candida Species Candidemia represents the fourth most common cause of nosocomial bloodstream infection in the United States [31].”
BackgroundInfluentialCurrent Treatment Strategies for Disseminated Candidiasis
Spellberg, B. J., Filler, S. G., & Edwards, J. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499057 · Cited by 256
“Candida species have become the third most common nosocomial bloodstream isolates and are exceeded in frequency only by coagulase-negative staphylococci and Staphylococcus aureus [1].”
Klotz, S. A., Chasin, B. S., Powell, B., Gaur, N. K., & Lipke, P. N. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.07.001 · Cited by 253
Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus
VANBELKUM, A., MELLES, D., NOUWEN, J., VANLEEUWEN, W., VANWAMEL, W., VOS, M., WERTHEIM, H., & VERBRUGH, H. (2009) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2008.09.012 · Cited by 251
“S. aureus ranks second as the cause of nosocomial blood stream infections that lead to increased morbidity, mortality, length of hospital stay, and costs (Pittet and Wenzel, 1995; Richards et al., 2000; Wisplinghoff et al., 2004; Wertheim et al., 2004).”
BackgroundMcKenzie, C. G. J., Koser, U., Lewis, L. E., Bain, J. M., Mora-Montes, H. M., Barker, R. N., Gow, N. A. R., & Erwig, L. P. (2010) · Infection and Immunity · doi:10.1128/iai.00001-10 · Cited by 250
“1 and 24 cases per 100,000 individuals and an associated mortality rate of more than 30% (42).”
BackgroundGenome-Wide Fitness Test and Mechanism-of-Action Studies of Inhibitory Compounds in Candida albicans
Xu, D., Jiang, B., Ketela, T., Lemieux, S., Veillette, K., Martel, N., Davison, J., Sillaots, S., Trosok, S., Bachewich, C., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030092 · Cited by 254
“Candida albicans is responsible for approximately 50% of all human life-threatening nosocomial fungal infections [1,2].”
BackgroundStaphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p
Peters, B. M., Ovchinnikova, E. S., Krom, B. P., Schlecht, L. M., Zhou, H., Hoyer, L. L., Busscher, H. J., van der Mei, H. C., Jabra-Rizk, M. A., & Shirtliff, M. E. (2012) · Microbiology · doi:10.1099/mic.0.062109-0 · Cited by 250
“Candida spp. and Staphylococcus spp. are among the leading pathogens causing nosocomial and bloodstream infections (Wisplinghoff et al., 2004).”
BackgroundPatients at High Risk of Invasive Fungal Infections: When and How to Treat
Rüping, M. J. G. T., Vehreschild, J. J., & Cornely, O. A. (2008) · Drugs · doi:10.2165/00003495-200868140-00002 · Cited by 253
“albicans remains the leading pathogen, counting for 8–10% of all isolates.[45] Populationcausing 62% of all invasive candidiases, C.”
BackgroundUpdate on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting
Navon-Venezia, S., Ben-Ami, R., & Carmeli, Y. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000171920.44809.f0 · Cited by 242
Pfaller, M. A., Moet, G. J., Messer, S. A., Jones, R. N., & Castanheira, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01079-10 · Cited by 238
“Hajjeh et al. (17) have shown that in 1998 through 2000, only 36% of Candida BSIs occurred in the ICU, whereas 28% were community onset (CO), an increase of almost 10% above that reported in 1992 and 1994 (19).”
ResultEnterococci and Their Interactions with the Intestinal Microbiome
Dubin, K., & Pamer, E. G. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0014-2016 · Cited by 239
“En-terococci are the second-most-common cause of health care-related bacteremia and are associated with an overall mortality of roughly 33% (25, 30).”
BackgroundSchmidt, C. S., White, C. J., Ibrahim, A. S., Filler, S. G., Fu, Y., Yeaman, M. R., Edwards Jr., J. E., & Hennessey Jr., J. P. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.038 · Cited by 230
“are now equivalent to enterococci as the third most frequent hospital acquired bloodstream isolates [3, 4], accounting for 10% of bloodstream infections and 11% of catheter-related infections [5].”
BackgroundMultiresistant Acinetobacter baumannii infections: epidemiology and management
Garnacho-Montero, J., & Amaya-Villar, R. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833ae38b · Cited by 236
Pham, C. D., Iqbal, N., Bolden, C. B., Kuykendall, R. J., Harrison, L. H., Farley, M. M., Schaffner, W., Beldavs, Z. G., Chiller, T. M., Park, B. J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03255-14 · Cited by 231
“hospitals, especially in intensive care units (1, 2).”
BackgroundOpportunistic invasive fungal infections: diagnosis & clinical management.
Badiee, P., & Hashemizadeh, Z. (2014) · PubMed Central · Cited by 331
Primary immunodeficiencies underlying fungal infections
Lanternier, F., Cypowyj, S., Picard, C., Bustamante, J., Lortholary, O., Casanova, J.-L., & Puel, A. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000031 · Cited by 230
“Candidemia is the fourth most important cause of nosocomial blood stream infection [111,112] and the most frequent IFD in Western countries [113], with a mortality rate of 40% [110].”
BackgroundBassetti, M., Merelli, M., Righi, E., Diaz-Martin, A., Rosello, E. M., Luzzati, R., Parra, A., Trecarichi, E. M., Sanguinetti, M., Posteraro, B., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01998-13 · Cited by 228
“This report shows that candidemia is a significant source of morbidity in Europe, causing a substantial burden of disease and mortality.”
BackgroundInfluentialRajendran, R., Sherry, L., Nile, C. J., Sherriff, A., Johnson, E. M., Hanson, M. F., Williams, C., Munro, C. A., Jones, B. J., & Ramage, G. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.09.018 · Cited by 228
“Published by El This is an o organisms responsible for all BSIs, and the third most common within the intensive-care unit [2], a clinical environment that is highly dependent on intravascular lines.”
BackgroundCoagulase-Negative Staphylococci Pathogenomics
Argemi, X., Hansmann, Y., Prola, K., & Prévost, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051215 · Cited by 218
“epidermidis is by far the most prevalent CoNS in microbiological samples and the primary cause of CoNS-related infections, particularly in nosocomial settings [56].”
BackgroundSchmiedel, Y., & Zimmerli, S. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14281 · Cited by 218
Pappas, P. G. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.07.004 · Cited by 227
Bougnoux, M.-E., Kac, G., Aegerter, P., d’Enfert, C., Fagon, J.-Y., & CandiRea Study Group (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0865-y · Cited by 224
“fourth among hospital-acquired bloodstream infections in North American hospitals [3].”
BackgroundWesth, H., Lisby, G., Breysse, F., Böddinghaus, B., Chomarat, M., Gant, V., Goglio, A., Raglio, A., Schuster, H., Stuber, F., et al. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02736.x · Cited by 228
“In the USA, a nationwide hospital study of 24 179 nosocomial bloodstream infections showed that the nine most frequent bacterial pathogens were all included in the ten most frequent pathogens found in the SENTRY surveillance, with Candida being the fourth most common pathogen isolated [3].”
BackgroundPliakos, E. E., Andreatos, N., Shehadeh, F., Ziakas, P. D., & Mylonakis, E. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00095-17 · Cited by 216
Wellinghausen, N., Kochem, A.-J., Disqué, C., Mühl, H., Gebert, S., Winter, J., Matten, J., & Sakka, S. G. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00567-09 · Cited by 223
“Bloodstream infection is a life-threatening condition with a high mortality rate, especially in intensive care and neutropenic patients (5, 19, 35, 38).”
BackgroundTrends in the Epidemiology of Invasive Fungal Infections
Warnock, D. W. (2007) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.48.1 · Cited by 226
Chow, J. K., Golan, Y., Ruthazer, R., Karchmer, A. W., Carmeli, Y., Lichtenberg, D., Chawla, V., Young, J., & Hadley, S. (2008) · Clinical Infectious Diseases · doi:10.1086/529435 · Cited by 223
“1086/529435 in intensive care units (ICUs), accounting for 10% of such infections [2].”
BackgroundBruder-Nascimento, A., Camargo, C., Sugizaki, M., Sadatsune, T., Montelli, A., Mondelli, A., & Bagagli, E. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-1 · Cited by 221
“A total of 212 clinical isolates of Candida spp., isolated from bloodstream infections - BSI (102 isolates), urinary tract infections - UTI (85 isolates) and and peritoneal fluid - PF (25 isolates), obtained from patients from Clinical Hospital of the UNESP School of Medicine, Botucatu, São Paulo State, between Januar…”
BackgroundInfluentialBillington, E. O., Phang, S. H., Gregson, D. B., Pitout, J. D. D., Ross, T., Church, D. L., Laupland, K. B., & Parkins, M. D. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.02.012 · Cited by 222
“0001 Vancomycin 28 (4) 6 (1) 12 (7) 0.”
Host Cell Invasion and Virulence Mediated by Candida albicans Ssa1
Sun, J. N., Solis, N. V., Phan, Q. T., Bajwa, J. S., Kashleva, H., Thompson, A., Liu, Y., Dongari-Bagtzoglou, A., Edgerton, M., & Filler, S. G. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001181 · Cited by 220
“albicans are associated with a 37% mortality [1].”
BackgroundBloodstream Infections Among Transplant Recipients: Results of a Nationwide Surveillance in Spain1
Moreno, A., Cervera, C., Gavaldá, J., Rovira, M., De La Cámara, R., Jarque, I., Montejo, M., De La Torre‐Cisneros, J., Miguel Cisneros, J., Fortún, J., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01964.x · Cited by 220
Silverman, R. J., Nobbs, A. H., Vickerman, M. M., Barbour, M. E., & Jenkinson, H. F. (2010) · Infection and Immunity · doi:10.1128/iai.00685-10 · Cited by 219
“Candida species are the fourth most common causative agents of nosocomial bloodstream infections (2, 47, 54).”
BackgroundDoi, A. M., Pignatari, A. C. C., Edmond, M. B., Marra, A. R., Camargo, L. F. A., Siqueira, R. A., da Mota, V. P., & Colombo, A. L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146909 · Cited by 215
“were the 4 most prevalent agent (4% of the total) [28].”
BackgroundSelf-citationHomothallic and heterothallic mating in the opportunistic pathogen Candida albicans
Alby, K., Schaefer, D., & Bennett, R. J. (2009) · Nature · doi:10.1038/nature08252 · Cited by 217
Cobos, M., De-La-Pinta, I., Quindós, G., Fernández, M. J., & Fernández, M. D. (2020) · Nanomaterials · doi:10.3390/nano10020376 · Cited by 218
“albicans is the most relevant fungal pathogen since Candida species are ranked as the fourth or fifth most common nosocomial bloodstream pathogen in the USA and some European countries, with mortality rates as high as 45% [44,49].”
BackgroundBench-to-bedside review: Candida infections in the intensive care unit
Méan, M., Marchetti, O., & Calandra, T. (2008) · Critical Care · doi:10.1186/cc6212 · Cited by 217
Bassetti, M., Taramasso, L., Nicco, E., Molinari, M. P., Mussap, M., & Viscoli, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024198 · Cited by 216
“is currently between the fourth and the sixth most common nosocomial bloodstream isolate in American and European studies [1,2].”
Background
Metadata
- Authors
- Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B.
- Affiliations
- University of Cologne (DE)
- Virginia Commonwealth University (US)
- Corresponding author
- Edmond, M. B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-01
- Volume
- 39
- Issue
- 3
- Pages
- 309-317
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171155970
- Cited by
- 4,496
- References
- 42
- Citations by year
- 2026: 78 · 2025: 138 · 2024: 137 · 2023: 171 · 2022: 209 · 2021: 187 · 2020: 229 · 2019: 252 · 2018: 215 · 2017: 238 · 2016: 255 · 2015: 271 · 2014: 291 · 2013: 257 · 2012: 241
- FWCI
- 105.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- nosocomial bloodstream infection, nosocomial infections, antibiotic resistance, methicillin-resistant Staphylococcus aureus, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, coagulase-negative staphylococci, candidiasis, intensive care unit, neutropenic patients, infectious disease epidemiology, temporal trends
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Child, Child, Preschool, Cross Infection, Drug Resistance, Microbial, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Prospective Studies, Staphylococcal Infections, United States, Causality, Incidence, Fungemia, Bacteremia, Gram-Negative Bacterial Infections, Gram-Positive Bacterial Infections, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.